Agony and ecstasy: a review of MDMA effects and toxicity
- 1 August 2000
- journal article
- review article
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 15 (5) , 287-294
- https://doi.org/10.1016/s0924-9338(00)00396-5
Abstract
Summary: Background: Background – Ecstasy is a recreational drug with an anecdotal reputation for safety. However, reports of adverse effects and fatalities have increased in the medical and popular press.Methods: Method – Literature search and review.Results: Results – Acute Ecstasy toxicity does not appear to be due to overdose and cannot be solely attributed to the nature of the usual ambient environment. Adverse effects include hyperthermia, seizures, cardiac arrhythmias, hepatotoxicity, hyponatraemia and many psychiatric disorders. Ecstasy causes serotonergic neurotoxicity in the brains of animals at doses close to those used by humans, but its long-term effect on the human brain is unknown.Conclusions: Conclusion – Ecstasy toxicity should be considered in the differential diagnosis of a variety of medical and psychiatric conditions. Given its popularity, both the acute and the potential long-term effects are a cause for concern.Keywords
This publication has 53 references indexed in Scilit:
- Reducedin vivobinding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) usersThe British Journal of Psychiatry, 1999
- Toxic effect of MDMA on brain serotonin neuronsThe Lancet, 1999
- Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxicationsAlimentary Pharmacology & Therapeutics, 1999
- Fatal interaction between ritonavir and MDMAThe Lancet, 1998
- Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated ImpulsivityNeuropsychopharmacology, 1998
- Acute liver damage and ecstasy ingestion.Gut, 1996
- Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”)Psychopharmacology, 1995
- The demethylenation of methylenedioxymethamphetamine (“ecstasy”) by debrisoquine hydroxylase (CYP2D6)Biochemical Pharmacology, 1994
- Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamineEuropean Journal of Pharmacology, 1990
- 'Eve' and 'Ecstasy'JAMA, 1987